Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia.

MLA

Chacko, Kieran I., et al. “Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus Faecium Bacteremia.” Antimicrobial Agents and Chemotherapy, vol. 62, no. 4, Mar. 2018. EBSCOhost, https://doi.org/10.1128/AAC.02007-17.

APA

Chacko, K. I., Sullivan, M. J., Beckford, C., Altman, D. R., Ciferri, B., Pak, T. R., Sebra, R., Kasarskis, A., Hamula, C. L., & van Bakel, H. (2018). Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia. Antimicrobial Agents and Chemotherapy, 62(4). https://doi.org/10.1128/AAC.02007-17

Chicago

Chacko, Kieran I, Mitchell J Sullivan, Colleen Beckford, Deena R Altman, Brianne Ciferri, Theodore R Pak, Robert Sebra, Andrew Kasarskis, Camille L Hamula, and Harm van Bakel. 2018. “Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus Faecium Bacteremia.” Antimicrobial Agents and Chemotherapy 62 (4). doi:10.1128/AAC.02007-17.